Loading...
OTCM
PTLF
Market cap22kUSD
Jul 28, Last price  
0.00USD
1D
0.00%
Jan 2017
-99.98%
IPO
-100.00%
Name

Petlife Pharmaceuticals Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
Net income
CFO

Profile

Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injectable version for direct administration to a tumor. In addition, the company develops edible dog and cat treats. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California.
IPO date
Jun 04, 2007
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

No data to show